Patent Case Watch

Patent opinions from the Eastern District of Texas and the U.S. Court of Appeals for the Federal Circuit

Fed. Cir.

Salix Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., No. 17-2636 (Fed. Cir. June 12, 2019)

Errata Correction sheet to a previously issued opinion
Errata
Court
U.S. Court of Appeals for the Federal Circuit
Case No.
No. 17-2636
Also Docketed
No. 18-1320 (consolidated; same document)
Decided
June 12, 2019
Judge
—
Document
Errata
Length
2 pages

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

NOTE: This disposition is nonprecedential. United States Court of Appeals for the Federal Circuit ______________________ July 11, 2019 ERRATUM ______________________ Appeal No. 2017-2312 DR. FALK PHARMA GMBH, Appellant v. GENERICO, LLC, FLAT LINE CAPITAL LLC, MYLAN PHARMACEUTICALS INC., Appellees -------------------------------------------------- Appeal Nos. 2017-2636, 2018-1320 SALIX PHARMACEUTICALS, INC., DR. FALK PHARMA GMBH, Plaintiffs-Appellants v.

Download Opinion (PDF)

Source: govinfo.gov USCOURTS collection · retrieved July 23, 2026 · Report an error

Other documents in this case